Obesity’s promotion of breast cancer via “as-yet-unknown mechanism” explained

46fd388d-d16d-4e83-9133-45378ddf02d9articleimage.jpg

23 Oct 2017 --- Obesity leads to the release of cytokines into the bloodstream which impact the metabolism of breast cancer cells, making them more aggressive as a result. This is according to scientists from Helmholtz Zentrum München, Technische Universität München (TUM) and Heidelberg University Hospital, who report on their findings in Cell Metabolism. The team also reports that it has already been able to halt this mechanism with an antibody treatment.

The number of people with obesity is increasing rapidly worldwide. The German Cancer Research Center (DKFZ) recently reported that according to the WHO the number of children and adolescents with obesity increased tenfold between 1975 and 2016.

Severe overweight can lead to various health impairments. Besides inducing cardiovascular diseases, obesity has also been found to promote the development of cancer and metastases.

“The current study elucidates an as-yet-unknown mechanism making breast cancer more aggressive. The enzyme ACC1* plays a central role in this process,” says Dr. Mauricio Berriel Diaz, Deputy Director of the Institute for Diabetes and Cancer (IDC) at Helmholtz Zentrum München. He led the study together with Stephan Herzig, Director of the IDC and Professor for Molecular Metabolic Control at TUM and Heidelberg University Hospital.

“ACC1 is a key component of fatty acid synthesis,” says Dr. Berriel Diaz. “However, its function is impaired by the cytokines leptin and TGF-β.” The levels of these cytokines are increased particularly in the blood of severely overweight subjects.

Fatty acid precursors promote metastases
The scientists demonstrated that the described inhibition of ACC1 leads to the accumulation of the fatty acid precursor acetyl-CoA. This precursor is transferred to certain gene “switches” that in turn increase the metastatic capacity of cancer cells by activating a specific gene program.

“Using human tissue from breast cancer metastases, we were able to show that ACC1 was significantly less active there,” says Marcos Rios Garcia, first author of the study. When the scientists blocked the as-yet-unknown signaling pathway with an antibody (directed against the leptin receptor), this led to a significantly reduced metastatic spread of breast cancer tumors in an experimental model.

In the future, the researchers want to substantiate the data on the newly discovered mechanism in further studies. In addition, they are also considering related intervention points that could be exploited therapeutically.

“Blocking the signaling pathways and switching off the metastasis-related genes could be a therapeutic target,” Herzig says. “As part of the so-called neoadjuvant therapy, the risk of metastases or the recurrence of tumors could be reduced prior to the surgical removal of the tumor.”

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

DuPont microbiome venture inks third partnership on probiotics

21 Jun 2018 --- A new collaboration with Institut National de la Recherche Agronomique (INRA) Micalis-MGP will concentrate on DuPont’s probiotic strains and the understanding of these microbes’ mechanism of action on human health. The move is hoped to continue DuPonts Microbiome Venture capacity building – through strategic partnerships – in microbiome innovation.

Nutrition & Health News

SlimBiome muesli to hit UK shelves

20 Jun 2018 --- Fruit, nut and seed supplier John Morley are teaming up with OptiBiotix health to deliver a weight-management breakfast muesli utilizing the SlimBiome technology. OptiBiotix’s patented Slimbiome claims to support weight-loss management by modifying the activity of the microbiome. The exclusive license granted to John Morley marks the first foray of SlimBiome into the UK breakfast market.

Nutrition & Health News

Personalized nutrition: Mindful and aware consumers drive market opportunity

19 Jun 2018 --- Personalized nutrition has taken its place as a key industry topic, spurring the launch of a number of innovative start-ups using cutting-edge technologies to offer precise nutrition advice to consumers. This growing industry space will be the topic of discussion at the Personalized Nutrition Innovation Summit, which is taking place in San Francisco on June 26-27.

Nutrition & Health News

Saturated fat increases risk of psychopathology, study suggests

19 Jun 2018 --- Adolescent rats who consume a diet high in saturated fats are at an increased risk of psychopathology in adulthood, a study published in the journal Brain, Behavior, and Immunity has found. Moreover, the researchers from Loma Linda University in California found that the areas of the brain that handle the fear/stress response were altered to the point that subjects began exhibiting behaviors that mirror post-traumatic stress disorder (PTSD). The findings could help researchers to target mental health illness in the coming generations and express the lasting, and potentially irreversible, effects of a poor diet.

Nutrition & Health News

DSM’s Nutrition Improvement focus: Fresh thinking on global nutrition and food fortification

15 Jun 2018 --- “We work with our customers and the larger malnutrition-fighting community to treat and prevent malnutrition,” Anthony Hehir, Director of DSM’s Nutrition Improvement Business Segment, tells NutritionInsight. Using its solid science and technical heritage, DSM is striving to fight global malnutrition through its “business with a purpose” approach. NutritionInsight spoke to Hehir, gaining an insight into what drives the company’s staple food fortification technologies, research and future nutrition endeavors. 

More Articles
URL : http://www.nutritioninsight.com:80/news/obesitys-promotion-of-breast-cancer-via-as-yet-unknown-mechanism-explained.html